AP2658A - Use of hydroxybenzoic acid ester and analogues forthe manufacture of a mendicament for the preventi on and treatment of virus infection - Google Patents

Use of hydroxybenzoic acid ester and analogues forthe manufacture of a mendicament for the preventi on and treatment of virus infection

Info

Publication number
AP2658A
AP2658A AP2008004351A AP2008004351A AP2658A AP 2658 A AP2658 A AP 2658A AP 2008004351 A AP2008004351 A AP 2008004351A AP 2008004351 A AP2008004351 A AP 2008004351A AP 2658 A AP2658 A AP 2658A
Authority
AP
ARIPO
Prior art keywords
mendicament
preventi
analogues
treatment
acid ester
Prior art date
Application number
AP2008004351A
Other languages
English (en)
Inventor
Qingmin Zhang
Original Assignee
Shenghua Guangzhou Pharmaceutical Science And Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenghua Guangzhou Pharmaceutical Science And Technology Co Ltd filed Critical Shenghua Guangzhou Pharmaceutical Science And Technology Co Ltd
Application granted granted Critical
Publication of AP2658A publication Critical patent/AP2658A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
AP2008004351A 2005-08-02 2006-07-21 Use of hydroxybenzoic acid ester and analogues forthe manufacture of a mendicament for the preventi on and treatment of virus infection AP2658A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100122870A CN100427082C (zh) 2005-08-02 2005-08-02 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用

Publications (1)

Publication Number Publication Date
AP2658A true AP2658A (en) 2013-05-09

Family

ID=37698614

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004351A AP2658A (en) 2005-08-02 2006-07-21 Use of hydroxybenzoic acid ester and analogues forthe manufacture of a mendicament for the preventi on and treatment of virus infection

Country Status (22)

Country Link
EP (1) EP1930002B1 (zh)
JP (1) JP5473328B2 (zh)
KR (1) KR100922605B1 (zh)
CN (1) CN100427082C (zh)
AP (1) AP2658A (zh)
AU (1) AU2006275232B2 (zh)
BR (1) BRPI0616536B8 (zh)
CA (1) CA2617659C (zh)
CY (1) CY1117480T1 (zh)
DK (1) DK1930002T3 (zh)
EA (1) EA016576B1 (zh)
ES (1) ES2567130T3 (zh)
HK (1) HK1113747A1 (zh)
HU (1) HUE027244T2 (zh)
IL (1) IL189162A (zh)
MX (1) MX2008001673A (zh)
NZ (1) NZ566153A (zh)
PL (1) PL1930002T3 (zh)
SI (1) SI1930002T1 (zh)
UA (1) UA90159C2 (zh)
WO (1) WO2007014515A1 (zh)
ZA (1) ZA200801635B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603522B (zh) * 2011-01-23 2015-04-22 复旦大学 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途
KR101401154B1 (ko) * 2011-02-22 2014-05-30 경희대학교 산학협력단 메틸 갈레이트를 포함하는 조절 ｔ 세포 활성 억제용 약학적 조성물
PL404138A1 (pl) * 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
CN103599093B (zh) * 2013-11-18 2016-06-01 中国医学科学院生物医学工程研究所 一种抗hpv药物制剂及用途
CN104784326A (zh) * 2014-05-15 2015-07-22 刘善奎 治疗***的中药栓剂
WO2017101873A1 (zh) 2015-12-18 2017-06-22 深圳瑞健生命科学研究院有限公司 一种预防或治疗放射性和化学性损伤的方法
TWI623321B (zh) * 2015-12-18 2018-05-11 Talengen Institute Of Life Sciences Co Ltd Method for preventing and treating cervical erosion
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人***瘤状病毒引起的疾病的药物和保健品中的应用
WO2019087881A1 (ja) * 2017-10-31 2019-05-09 富士フイルム株式会社 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
JPWO2019087888A1 (ja) * 2017-10-31 2020-11-12 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
JPWO2019087884A1 (ja) * 2017-10-31 2020-11-19 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
CN111419833B (zh) * 2020-06-02 2023-04-07 上海爱启医药技术有限公司 没食子酸的药物应用
CN114146082A (zh) * 2020-09-07 2022-03-08 盈科瑞（横琴）药物研究院有限公司 对羟基苯甲酸甲酯及其钠盐抗冠状病毒的用途
CN112375803B (zh) * 2020-11-16 2024-05-07 石河子大学 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929985A (en) * 1974-01-18 1975-12-30 Richardson Merrell Inc Anhydrous candicidin foam compositions
JPS62132824A (ja) * 1985-12-05 1987-06-16 Eisai Co Ltd 肝炎への治療剤
SE464167B (sv) * 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
CN1042298C (zh) * 1989-07-31 1999-03-03 安纳利蒂康有限公司 含鬼臼毒的乳膏形式的药物组合物的制备方法
CN1068782A (zh) * 1992-01-30 1993-02-10 展静 轮胎气压报警装置
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
DE19514694A1 (de) * 1995-04-13 1996-10-17 Ina Dr Levi Breitspektrum-Antiinfektivamittel
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
CN1068782C (zh) * 1996-04-18 2001-07-25 中国医药研究开发中心 以栾树提取物为有效组分的抗癌药物及制备方法
JPH09328404A (ja) * 1996-06-07 1997-12-22 Iwao Hishida 殺菌、抗菌および不活化剤
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
DE60105452T2 (de) * 2001-05-03 2005-10-13 Farmigea S.P.A. Sucralfat enthaltendes arzneimittel zur behandlung von zervikale erosion

Also Published As

Publication number Publication date
CA2617659A1 (en) 2007-02-08
EP1930002B1 (en) 2016-01-06
CN1907276A (zh) 2007-02-07
KR100922605B1 (ko) 2009-10-21
IL189162A0 (en) 2008-08-07
EP1930002A4 (en) 2010-04-21
IL189162A (en) 2014-04-30
NZ566153A (en) 2011-07-29
BRPI0616536B1 (pt) 2020-05-26
MX2008001673A (es) 2008-11-06
CA2617659C (en) 2013-02-26
CY1117480T1 (el) 2017-04-26
ZA200801635B (en) 2009-06-24
KR20080036128A (ko) 2008-04-24
WO2007014515A1 (fr) 2007-02-08
DK1930002T3 (en) 2016-04-11
CN100427082C (zh) 2008-10-22
SI1930002T1 (sl) 2016-06-30
HK1113747A1 (zh) 2008-10-17
JP2009502985A (ja) 2009-01-29
PL1930002T3 (pl) 2016-07-29
JP5473328B2 (ja) 2014-04-16
AU2006275232A1 (en) 2007-02-08
HUE027244T2 (en) 2016-09-28
EA016576B1 (ru) 2012-06-29
AU2006275232B2 (en) 2010-12-02
ES2567130T3 (es) 2016-04-20
UA90159C2 (ru) 2010-04-12
EP1930002A1 (en) 2008-06-11
BRPI0616536A2 (pt) 2012-12-25
BRPI0616536B8 (pt) 2021-05-25
EA200800467A1 (ru) 2008-10-30

Similar Documents

Publication Publication Date Title
AP2658A (en) Use of hydroxybenzoic acid ester and analogues forthe manufacture of a mendicament for the preventi on and treatment of virus infection
EP2074140B8 (en) Fibrillation-resistant insulin and insulin analogues
HK1098127A1 (en) Hydroxamic acid esters and pharmaceutical use thereof
TWI369210B (en) Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
IL186194A0 (en) Markers associated with the therapeutic efficacy of glatiramer acetate
IL190478A0 (en) Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
HRP20130622T1 (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
IL240118A0 (en) Biological glue without thrombin and its use as a medicine
AP2413A (en) 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other disease.
EP1902715A3 (en) Use of paliperidone for the treatment of psychiatric patients with reduced hepatic function
EP2392336A3 (en) Use of 24-norUDCA
EP1874722A4 (en) HYDROXAMIC ACID DERIVATIVES AND PROCESSES FOR PREPARING THE SAME
EP1852432A4 (en) NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE
AU2003249191A1 (en) Low polarity dimerate and trimerate esters as plasticizers for elastomers
AU2003285946A8 (en) Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases
EP1736168A4 (en) INHIBITOR OF PROSTHESIS AND PREVENTIVES OR REMEDIES FOR DISEASES.
EP1841747A4 (en) DERIVATIVES OF OXAZOLE HYDROXAMIC ACID AND ITS USE
WO2006095173A3 (en) Medical uses of 39-desmethoxyrapamycin and analogues thereof
ZA200801248B (en) PEG-IFN alpha and ribaviriin for HBV treatment
IL189939A0 (en) Inhibitors of the hiv integrase enzyme
IL182601A0 (en) The use of a protease or a protease inhibitor for the manufacture of medicaments
IL191208A (en) Use of phenofibrate or its derivative for the preparation of a drug for the treatment of diabetic retinopathy
PL372181A1 (pl) Nowe estry niesteroidowych leków przeciwzapalnych i sposób ich wytwarzania